Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune status SAN DIEGO, March 1 ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

PRNewswire/ - Eupraxia Pharmaceuticals Inc. (Eupraxia or the Company) (NASDAQ:EPRX ) (TSX:EPRX), a clinical-stag ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced participation in the ...

A swarm of dust storms and tornadoes tore across the southern United States over the weekend, killing at least 39 people and ...

The funding can support investment in as many as 60 new life sciences companies, said Sofinnova chairman Antoine Papiernik.

The Golden Knights were “talking about moving” from T-Mobile Arena and “want to discuss moving to what we build,” said Mark ...

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

Indeed, based on the Bitcoin Fear and Greed Index, which has been at Fear to Extreme Fear levels for almost a month now, one ...

among other states affected Trump in a statement Sunday evening said they were "actively monitoring" the storm activity and had deployed the National Guard to Arkansas. "My Administration is ready ...

Major cryptocurrency exchange Bybit said all of its liquidation data is now publicly available through an upgrade to its application programming interface (API). With the upgrade, the API delivers ...